Anterogen Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 37

Employees

  • Stock Symbol
  • 065660

Stock Symbol

  • Share Price
  • $11.03
  • (As of Friday Closing)

Anterogen General Information

Description

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Corporate Office
  • 345-30 Gasan-dong
  • Geumcheon-gu
  • Seoul, 08589
  • South Korea
+82 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anterogen Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.03 $11.11 $9.09 - $14.16 $107M 9.7M 49.3K -$0.27

Anterogen Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 71,992 99,166 82,350 470,506
Revenue 4,913 4,972 5,101 7,090
EBITDA (2,424) (1,884) (4,166) 1,026
Net Income (2,612) (2,173) (5,291) (484)
Total Assets 89,618 115,957 98,291 114,873
Total Debt 0 7,558 10,065 9,891
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anterogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anterogen‘s full profile, request access.

Request a free trial

Anterogen Patents

Anterogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230167143-A1 Prodrugs of l-bhdu and methods of treating viral infections Active 29-Oct-2021 00000000000
AU-2022378641-A1 Prodrugs of l-bhdu and methods of treating viral infections Pending 29-Oct-2021 00000000000
US-11945833-B2 Prodrugs of l-bhdu and methods of treating viral infections Active 29-Oct-2021 00000000000
CA-3235899-A1 Prodrugs of l-bhdu and methods of treating viral infections Pending 29-Oct-2021 00000000000
US-20220175666-A1 Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same Pending 21-Mar-2019 A61P29/00
To view Anterogen’s complete patent history, request access »

Anterogen Executive Team (4)

Name Title Board Seat Contact Info
Mi-hyung Kim Chief Executive Officer & Board Member
Sung-Koo Lee Co-Chief Executive Officer & Board Member
Lee Seong-gu Co-Chief Executive Officer
Ike Lee Ph.D Founder
To view Anterogen’s complete executive team members history, request access »

Anterogen Board Members (2)

Name Representing Role Since
Mi-hyung Kim Anterogen Chief Executive Officer & Board Member 000 0000
Sung-Koo Lee Anterogen Co-Chief Executive Officer & Board Member 000 0000
To view Anterogen’s complete board members history, request access »

Anterogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anterogen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anterogen‘s full profile, request access.

Request a free trial

Anterogen ESG

Risk Overview

Risk Rating

Updated May, 18, 2022

30.75 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 14,912

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 965

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 443

Rank

00.00

Percentile

To view Anterogen’s complete esg history, request access »

Anterogen FAQs

  • When was Anterogen founded?

    Anterogen was founded in 2000.

  • Who is the founder of Anterogen?

    Ike Lee Ph.D is the founder of Anterogen.

  • Who is the CEO of Anterogen?

    Mi-hyung Kim, Sung-Koo Lee, and Lee Seong-gu are the CEOs of Anterogen.

  • Where is Anterogen headquartered?

    Anterogen is headquartered in Seoul, South Korea.

  • What is the size of Anterogen?

    Anterogen has 37 total employees.

  • What industry is Anterogen in?

    Anterogen’s primary industry is Biotechnology.

  • Is Anterogen a private or public company?

    Anterogen is a Public company.

  • What is Anterogen’s stock symbol?

    The ticker symbol for Anterogen is 065660.

  • What is the current stock price of Anterogen?

    As of 14-Jun-2024 the stock price of Anterogen is $11.03.

  • What is the current market cap of Anterogen?

    The current market capitalization of Anterogen is $107M.

  • What is Anterogen’s current revenue?

    The trailing twelve month revenue for Anterogen is $4.91M.

  • What is Anterogen’s annual earnings per share (EPS)?

    Anterogen’s EPS for 12 months was -$0.27.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »